References
- CHEN, J. L., YEH, M. K. and CHIANG, C. H., 2002, The mechanism of PLG microparticle formation by water in-oil in-water solvent evaporation method. Journal of Microencapsulation, 19, 333–346.
- CLEMENS, J. D., STANTON, B. F. CHAKRABORTY, J., SACK, D. A., KHAN, H. R., HUDA S., AHMED, F., HARRIS, J. R., Yumus, M., KHAN, M. U., SVENNERHOLM, A. M., JERTHORN, M. and HOLMGREN, J., 1987, B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. Journal of Infectious Diseases, 155, 79–85.
- COOMBES, A. G. A., TASKER, S., LINDBLAD, M., HOLMGREN, J., HOSTE, K., TONCHEVA, V., SCHACHT, E., DAVIES, M. C., ILLum, L. and DAVIS, S. S., 1997, Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Biomaterials, 18, 1153–1161.
- COOMBES, A. G. A., YEH, M. K., LAVELLE, E. C. and DAVID, S. S., 1998, The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Journal of Controlled Release, 52, 311–320.
- EAVELLE, E. C., YEH, M. K., COOMBES, A. G. A. and DAVIS, S. S., 1999, The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Vaccine, 17, 512–529.
- FINKELSTEIN, R. A., 1995, Why do we not yet have a suitable vaccine against cholera? Advances in Experimental Medicine and Biology, 37111, 1633–1640.
- GUPTA, R. K., CHANG, A. C. and SIBER, G. R., 1998, Biodegradable polymer micro-spheres as vaccine adjuvants and delivery systems. Developments in Biological Standardization, 92, 63–78.
- HOLMGREN, J., LYCKE, N. and CZERKINSKY, C., 1993, Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine, 11, 1179–1184.
- JIANG, W. and SCHWENDEMAN, S. P., 2001, Stabilization and controlled release of bovine serum albumin encapsulated in poly(d/-lactide) and poly(ethylene glycol) microsphere blends. Pharmaceutical Research, 18, 878–885.
- JUNG, T., KAMM, W., BREITENBACH, A., HUNGERER, K., HUNDT, E. and KISSEL, T., 2001, Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl-alcohol)-graft-poly(lactide co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharmaceutical Research, 18, 352–360.
- KERNEIS, S., BOGDANOVA, A., KRAEHENBUHL, J. P. and PRINGAULT, E., 1997, Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science, 277, 949–952.
- KIM, S. Y., DOH, H. J., JANG, M. H., HA, Y. J., CHUNG, S. I., PARK, H. J., 1999, Oral immunization with Helicobacter pylori-loaded poly(D,L-lactide-co-glycolide) nanoparticles. Helicobacter, 4, 33–39.
- KOFLER, N., RUEDL, C., RIESER, C., WICK, G. and WOLF, H., 1997, Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens. International Archives of Allergy and Immunology, 113, 424–431.
- LEGROS, D., PAQUET, C., PEREA, W., MARTY, I., MUGISHA, N. K., ROGER, H., NEIRA, M., and IVANOFF, B., 1999, Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bulletin of the World Health Organization, 77, 837–842.
- D'HAGAN, D. T., 1998, Recent advances in vaccine adjuvants for systemic and mucosal administration. Journal of Pharmacy and Pharmacology, 50, 1–10.
- D'HAGAN, D. T., McGEE, J. P., LINDBLAD, M. and HOLMGREN, T., 1995, Cholera Toxin submit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mined with whole cholera toxin following oral administration. International Journal of Pharmacology, 119, 251–255.
- PIZZA, M., GIULIANI, M. M., FONTANA, M. R., MONACI, E., DOUCE, G., DOUGAN, G., MILLS, K. H. G., RAPPUOLI, R. and DEL GIUDICE, G., 2001, Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine, 19, 2534–2541.
- RASK, C., FREDRIKSSON, M., LINDBLAD, M., CZERKINSKY, C. and HOLMGREN, J., 2000, Mucosal and systemic antibody responses after oral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 108, 178–186.
- THOMAS, N. W., JENKINS, P. G., HOWARD, K. A., SMITH, M. W., LAVELLE, E. C., JOLLAR, J., and DAVIS, J. S., 1996, Particle uptake and translocation across epithelial membranes. Journal of Anatomy, 189, 487–490.
- THOMASIN, C., CORRADIN, G., MEN, Y., MERKLE, H. P. and GANDER, B., 1996, Tetanus toxoid and synthetic malaria antigen containing poly (lactide)/poly (lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. Journal of Controlled Release, 41, 131–145.
- YEH, M. K., CHEN, J. L. and CHIANG, C. H., 2002a, Vibrio cholerae-loaded microparticles as oral-mucosal adjuvant and antigen vector systems. Journal of Controlled Release, 82, 237–247.
- YEH, M. K., CHEN, J. L. and CHIANG, C. H., 2002b, Vibrio cholerae-loaded poly(DL lactide co-glycolide) Microparticles. Journal of Microencapsulation, 19, 203–212.
- YEH, M. K., JENKINS, P. G., DAVID, S. S. and COOMBES, A. G. A., 1995, Improving the delivery capacity of microparticle system using blend of poly(DL lactide co-glycolide) and poly(ethylene glycol). Journal of Controlled Release, 37, 1–9.